sorafenib - Robuta Search

https://www.frontiersin.org/journals/coatings-dyes-and-interface-engineering/articles/10.3389/frcdi.2025.1531144/full Frontiers | Doxorubicin and sorafenib release from mesoporous silica nanoparticles coated with... In this paper, we present results of a study on the influence of different experimental conditions on drug release, for the two anticancer drugs: doxorubicin... mesoporous silica frontiers doxorubicin sorafenib release https://www.nice.org.uk/guidance/ta178/history History | Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and... Evidence-based recommendations on bevacizumab (Avastin), sorafenib (Nexavar), sunitinib (Sutent) and temsirolimus (Torisel) for treating advanced or metastatic... first line history bevacizumab sorafenib second https://www.wipo.int/wipolex/es/judgments/details/3094 WIPO Lex, Alemania, Federal Court of Justice, 28.11.2023, X ZR 83/21 - Sorafenib-Tosylat Alemania - Fecha de la sentencia: 28 de noviembre de 2023 - Tribunal Federal de Justicia (Bundesgerichtshof) - Instancia Final - Judicial (Civil) - Patentes... https://stanfordhealthcare.org/trials/s/NCT00064350.html Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer Stanford Health Care delivers the highest levels of care and compassion. SHC treats cancer, heart disease, brain disorders, primary care issues, and many more. small cell sorafenib treating patients https://www.medlineplus.gov/druginfo/meds/a607051.html Sorafenib: MedlinePlus Drug Information Sorafenib: learn about side effects, dosage, special precautions, and more on MedlinePlus sorafenib medlineplus drug information https://www.rcsb.org/structure/3GCS RCSB PDB - 3GCS: Human P38 MAP kinase in complex with Sorafenib Human P38 MAP kinase in complex with Sorafenib p38 map kinase rcsb pdb human https://pmc.ncbi.nlm.nih.gov/articles/PMC6635829/ The combination of the glycolysis inhibitor 2-DG and sorafenib can be effective against... Chemotherapy remains a major clinical option for the successful treatment of cancer by eliminating fast-growing populations of cancer cells. However, drug... https://www.mdpi.com/1420-3049/27/22/8082 Effects of Sorafenib and Quercetin Alone or in Combination in Treating Hepatocellular Carcinoma: In... Sorafenib is the first drug approved to treat advanced hepatocellular carcinoma (HCC) and continues as the gold-standard therapy against HCC. However, acquired... https://www.news-medical.net/news/20260123/Cigarette-compound-exposure-drives-sorafenib-resistance-in-hepatocellular-carcinoma.aspx Cigarette compound exposure drives sorafenib resistance in hepatocellular carcinoma Jan 23, 2026 - A research team led by Professor Yuan Li at Nanjing Medical University published a research paper entitled "A Cigarette Compound-Induced Tumor Microenvironment... cigarette compound exposure drives sorafenib https://pmc.ncbi.nlm.nih.gov/articles/PMC11897632/ Key prognostic factors in transarterial chemoembolization combined with sorafenib treatment for... Background: Hepatocellular carcinoma (HCC) is a prevalent malignancy worldwide, with portal vein tumor thrombosis (PVTT) worsening its prognosis and... prognostic factors key https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-comparing-lenavatinib-sorafenib-for-primary-liver-cancer A trial comparing lenvatinib and sorafenib for primary liver cancer This trial is comparing lenvatinib with sorafenib for people with a type of primary liver cancer called hepatocellular carcinoma. a trial for primary comparing lenvatinib sorafenib https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCT01371981&r=1 Bortezomib and Sorafenib Tosylate in Treating Patients with Newly Diagnosed Acute Myeloid Leukemia... Bortezomib and Sorafenib Tosylate in Treating Patients with Newly Diagnosed Acute Myeloid Leukemia https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-cabozantinib-for-primary-liver-cancer-that-had-got-worse-despite-having-sorafenib A trial looking at cabozantinib for primary liver cancer that had got worse despite having sorafenib This trial looked at cabozantinib for people with the most common type of primary liver cancer called hepatocellular carcinoma or HCC. https://www.semanticscholar.org/topic/sorafenib/25688 sorafenib | Semantic Scholar A drug used to treat advanced kidney cancer and a type of liver cancer that cannot be removed by surgery. It is also being studied in the treatment of other... sorafenib semantic scholar https://www.ebi.ac.uk/chebi/CHEBI:50928 sorafenib tosylate (CHEBI:50928) sorafenib tosylate chebi https://www.mdedge.com/content/sorafenib-results-mixed-advanced-melanoma Sorafenib Results Mixed For Advanced Melanoma | MDedge for advanced sorafenib results mixed melanoma https://www.goodrx.com/nexavar/what-is Nexavar (sorafenib): Uses, Side Effects, Dosage & Reviews Learn about Nexavar (sorafenib) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives. side effects nexavar sorafenib uses dosage https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.673378/full Frontiers | Sorafenib Versus Apatinib Both Combined Transarterial Chemoembolization for... AbstractObjective: To compare the efficacy and safety of transarterial chemoembolization (TACE) combining with sorafenib or with apatinib for hepatocellular ... frontiers sorafenib versus apatinib combined https://www.nice.org.uk/guidance/ta178/chapter/5-Implementation 5 Implementation | Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib... Evidence-based recommendations on bevacizumab (Avastin), sorafenib (Nexavar), sunitinib (Sutent) and temsirolimus (Torisel) for treating advanced or metastatic... first line 5 implementation bevacizumab sorafenib https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1336 Compound: SORAFENIB (CHEMBL1336) - ChEMBL Report card for Compound SORAFENIB (CHEMBL1336). C21H16ClF3N4O3, Small molecule, BAY 43-9006, BAY-43-9006, SORAFENIB. compound sorafenib chembl https://www.indiamart.com/digitalsolutionmaharashtra/?pid=25283682855&c_id=743&mid=166229&pn=Sorafenib%20Tosylate%20Tablets%20Ip%20200%20Mg Digital Solution, Mumbai - Trader - Retailer of Pharmaceutical Tablets and Sorafenib Tosylate Tablet digital solution https://pmc.ncbi.nlm.nih.gov/articles/PMC10695342/ Efficacy and safety comparison between Lenvatinib and Sorafenib in hepatocellular carcinoma... Our study aimed to evaluate the efficacy and safety of Lenvatinib compared with Sorafenib for treating hepatocellular carcinoma (HCC) patients under real-world... efficacy and safety comparison lenvatinib sorafenib hepatocellular https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.1101351/full Frontiers | Efficacy and safety of transarterial chemoembolization plus sorafenib in patients with... Objectives: To explore the benefit and safety of transarterial chemoembolization (TACE) in combination with sorafenib in patients with recurrent hepatocellul... efficacy and safety https://www.indiamart.com/digitalsolutionmaharashtra/ Digital Solution, Mumbai - Trader - Retailer of Pharmaceutical Tablets and Sorafenib Tosylate Tablet digital solution https://patient.info/medicine/sorafenib-tablets-nexavar Sorafenib tablets - Nexavar. Liver and kidney cancer treatment Sorafenib tablets are used in the treatment of Cancer (such as kidney cancer and liver cancer). Sorafenib tablets are often sold as Nexavar tablets sorafenib tablets kidney cancer nexavar liver treatment https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-sorafenib-in-combination-with-2-other-treatments-for-liver-cancer-soramic A trial of sorafenib in combination with 2 other treatments for liver cancer (SORAMIC) Description: This trial is looking at a drug called sorafenib in combination with selective internal radiation therapy or radiofrequency ablation to treat https://www.mdpi.com/1422-0067/21/5/1875 Assessment of the Effect of Sorafenib on Omega-6 and Omega-3 Epoxyeicosanoid Formation in Patients... Hepatocellular carcinoma (HCC) is a leading cause of cancer death. The multikinase inhibitor sorafenib is widely used for systemic therapy in advanced HCC.... https://www.spandidos-publications.com/10.3892/ol.2021.13068/abstract Response of human cancer cells to simultaneous treatment with sorafenib and radiofrequency current Oncology Letters is an international journal devoted to Experimental and Clinical Oncology. https://www.nice.org.uk/guidance/ta178/chapter/4-Evidence-and-interpretation 4 Evidence and interpretation | Bevacizumab (first-line), sorafenib (first- and second-line),... Evidence-based recommendations on bevacizumab (Avastin), sorafenib (Nexavar), sunitinib (Sutent) and temsirolimus (Torisel) for treating advanced or metastatic... first line 4 evidence interpretation bevacizumab https://www.doccheck.com/de/detail/photos/40587-sorafenib Sorafenib - DocCheck Strukturformel Sorafenib, Public Domain sorafenib doccheck https://www.researchandmarkets.com/report/sorafenib-market Sorafenib Market Size, Competitors & Forecast to 2030 The Sorafenib Market, valued at USD 1.34B in 2026, is projected to reach USD 1.56B by 2030, growing at a 3.9% CAGR. market size sorafenib competitors forecast 2030 https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.709343/full Frontiers | Activation of FcRn Mediates a Primary Resistance Response to Sorafenib in... Sorafenib is the first-line therapeutic option for advanced hepatocellular carcinoma (HCC). Many patients exhibit a primary resistance (PR) response after in... https://www.growkudos.com/publications/10.1136%25252Fgutjnl-2019-318830/reader miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by... Autophagy participates in the progression of cancer and the resistance of hepatocellular carcinoma (HCC) to sorafenib. Here we reported that miR-541 was... https://www.news-medical.net/news/20150225/Sorafenib-sunitinib-provide-no-benefit-to-patients-with-locally-advanced-kidney-cancer.aspx Sorafenib, sunitinib provide no benefit to patients with locally advanced kidney cancer Jun 18, 2019 - Findings from a federally funded study suggest that patients with locally advanced kidney cancer should not be treated with either adjuvant (post-surgery)... to patients https://www.cancer.gov/news-events/press-releases/2018/sorafenib-desmoid-trial Sorafenib improved progression-free survival in desmoid tumor study - NCI In an NCI-funded trial for patients with desmoid tumors or aggressive fibromatosis (DT/DF), rare sarcomas with limited treatment options, the drug sorafenib... progression free survival desmoid tumor sorafenib improved study https://www.epo.org/fr/boards-of-appeal/decisions/t110790eu1 T 0790/11 (Sorafenib combination therapy/BAYER) du 19.04.2017 combination therapy 19 04 11 sorafenib https://zumvu.com/oddwayinternational/post/63273/ Oddway International - Kidney Cancer Treatment Sorafenat 200mg Generic Sorafenib Nexavar #sorafenat #sorafenib #nexavar #indiannexavar #sorafenatprice #sorafenibsupplier #cancer kidney cancer treatment international 200mg generic sorafenib https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCT01371981 Bortezomib and Sorafenib Tosylate in Treating Patients with Newly Diagnosed Acute Myeloid Leukemia... Bortezomib and Sorafenib Tosylate in Treating Patients with Newly Diagnosed Acute Myeloid Leukemia https://www.sciencedaily.com/releases/2017/02/170217162331.htm Micro-RNA may amplify effectiveness of sorafenib in difficult liver cancer cases | ScienceDaily Only 25% of patients respond to sorafenib treatment, so researchers have endeavored to understand its mechanism of action and discover a way to boost its... https://www.cancerresearchuk.org/about-cancer/treatment/drugs/sorafenib Sorafenib | Cancer Research UK Sorafenib is a type of targeted cancer drug called a cancer growth blocker. It is a treatment for a certain type of liver, thyroid cancer and advanced kidney... cancer research sorafenib uk https://www.vidal.fr/medicaments/gammes/sorafenib-biogaran-103917.html SORAFENIB BIOGARAN sorafenib biogaran https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-comparing-tki258-sorafenib-kidney-cancer A trial comparing dovitinib with sorafenib in kidney cancer This trial compared a new drug called dovitinib (also called TKI258) with sorafenib in people with kidney cancer. a trial comparing dovitinib sorafenib kidney https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1478596/full Frontiers | Sorafenib combined with tarexib for first-line treatment of unresectable hepatocellular... BackgroundThis study aims to evaluate the safety efficacy of combining the PD-1 antibody Tirelizumab with Sorafenib in the treatment of advanced hepatocellul... first line treatment https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.913736/full Frontiers | Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by... Background. Sorafenib, a kinase inhibitor, is a standard treatment for advanced hepatocellular carcinoma (HCC) but provides only a limited survival benefit. ... hepatocellular carcinoma frontiers improving therapeutic efficacy https://pmc.ncbi.nlm.nih.gov/articles/PMC12657762/ Lenvatinib vs. sorafenib as second-line treatment post atezolizumab plus bevacizumab for... Atezolizumab plus bevacizumab (A+B) is a standard first-line systemic therapy for unresectable hepatocellular carcinoma (HCC). However, optimal sequencing... second line treatment https://www.medicines.org.uk/emc/product/13098/pil Sorafenib 200mg film-coated tablets - Patient Information Leaflet (PIL) - (emc) | 13098 Sorafenib 200mg film-coated tablets - Patient Information Leaflet (PIL) by Zentiva patient information leaflet film coated sorafenib 200mg tablets https://www.ncbi.nlm.nih.gov/Structure/pdb/3WZE 3WZE: KDR in complex with ligand sorafenib Vascular endothelial growth factor receptor... kdr complex ligand sorafenib